Our Story

Our adventure began in 2013 when founder, Eugenio Iannone joined forces with designer, Giacomo Germani to develop the first lab-on-a-chip capable of bringing diagnostics to the patient.

With a degree in electronic engineering and over 35 years’ experience in the telecommunications industry at Cisco Systems and Pirelli Labs, Eugenio was adept at designing innovative products based on cutting-edge technologies. Then, the diagnosis of a genetic renal disease changed his life completely. With over four years on dialysis and trips to the hospital every other day, his life was effectively on hold until he finally received a kidney transplant in 2012. Having spent his time in dialysis writing the definitive guide to labs-on-chips, and aware of an ever-increasing urgency to bring healthcare to the patient, Eugenio set about finding an elegant and effective solution to the problem. He teamed up with Giacomo, found support from several angel investors and the rest is history …

Except really our story is only just beginning.

dianax is no longer the passion of one man. It is the passion of a growing international team of experienced, dynamic and hard-working experts who, first and foremost, want to add value to the lives of patients by bringing healthcare closer.
They understand that for patients and their physicians, the ability to bring testing to the POINT OF NEED and to KNOW NOW is life-changing, cost-saving and, without doubt, the future of diagnostics.

The secret of our success?

Our People

Eugenio Iannone

Founder

“Our mission is to give people living with chronic disease more freedom by…

Andrea Zanella

Chief Executive Officer and Board Member

“Our vision is to move healthcare diagnostics (screening, diagnostics…

Pascal Pouligny

Chief Marketing Officer

“The diagnostics industry is on the cusp of a major transformation, powered by…

Princia Salvatore

Valentina Greco

Martina Mattii

Monica Gioe

Andrea Toma

Daniela Stevar

Antonio Caltabiano

Gea Bianchi

Giacomo Germani

Board of Directors

Two of our management team both sit on the board, Eugenio Iannone (Deputy Chairman) and Andrea Zanella. We are also indebted to the following well-respected executives in the venture capital and healthcare industries, whose support, advice and guidance has been invaluable in our quest to become the leading lab-on-a-chip diagnostics company.

It is not too late if you want a piece of the action and are keen to invest in the transformation of one of the fastest-growing segments of the in vitro diagnostics market. Visit Investors & Partners and/or contact our CEO for more information.

Board of Directors

Chief Executive Officer, Andrea Zanella, sits on the board and we are also indebted to the following well-respected executives in the venture capital and healthcare industries, whose support, advice and guidance has been invaluable in our quest to become the leading lab-on-a-chip diagnostics company.

Corrado Ruffini, President and Chairman of the Board

Gabriele Bavagnoli, Co-CEO Spactiv

Roberto Zanco, Managing Partner, RedSeed

Carlo Giovanni Conti, Managing Partner, Padda Srl.

Clinical Advisory Board

Bringing key European subject matter experts together…

Chantal Mathieu, MD, PhD

Lorenzo Piemonti, MD

Anders Larsson, MD, PHD

Michelangelo Bortolin, MD

Clara Camaschella, MD

Clinical Advisory Board

Bringing key European subject matter experts together…

Chantal Mathieu, MD, PhD

Former Director Emeritus, McKinsey and Company Inc. Read More

Lorenzo Piemonti, MD

Gabriele orchestrated the initial fundraising leading to the foundation of the company and was our first investor. Read More

Clara Camaschella, MD

Gabriele orchestrated the initial fundraising leading to the foundation of the company and was our first investor. Read More

Anders Larsson, MD, PhD

Gian led teams of Private Equity professionals worldwide as Managing Director… Read More

Michelangelo Bortolin, MD

RedSeed is a venture capital firm focused on seed and early-stage investments in the healthcare and digital sector. Read More

Clinical Advisory Board

Bringing key European subject matter experts together…

[unique_overlay unique-id = '26027']

*Products/devices are under development but not yet approved for use. For investigational use only.

GET IN
TOUCH

We are always happy to hear from interested parties. Contact us anytime, anywhere if you need to KNOW NOW.



MAIL

dianax@dianax.eu



CALL

+39 02 566 602 23



FIND US

Milan, Italy

Eugenio Iannone

Founder

“Our mission is to give people living with chronic disease more freedom by allowing clinical tests to happen exactly when and where they’re needed"

35-year career in semiconductor research and development (Cisco Systems, PGT Photonics, Pirelli Labs)
100 scientific publications; 10 international patents
Seminal book author of ‘Labs on Chip: Principles, Design and Technology,’ the definitive reference for labs-on-chips in biotechnology

Andrea Zanella

Chief Executive Officer and Board Member

“Our vision is to move healthcare diagnostics (screening, diagnostics, monitoring) out of the lab without compromising accuracy and reliability, so that more than 30% of all common blood tests are done where they are needed, decreasing the overall healthcare cost and enhancing the patients’ experience”

32 years’ experience in medical devices, in-vitro diagnostics and life science research (Bellco-Medtronic, Pfizer-Shiley, Sorin Group Livanova, Gambro-Baxter, Becton Dickinson)
President, VP/General Manager in several international corporations with expertise in sales, marketing and business development, as well as R&D and operations. Also served as Vice-Chairman at Assobiomedicali Trade Association
Biomedical Engineering PhD from Politecnico di Milano University; Master in Marketing at SDA-Bocconi University; MBA at ISVOR Fiat Business School; fluent in English, Italian and French

Pascal Pouligny

Chief Marketing Officer

“The diagnostics industry is on the cusp of a major transformation, powered by miniaturization, reduced costs and a surge in mobile technologies. This will result in a new generation of decentralized tests that can be run in doctors’ offices, at pharmacies or in people’s homes, with zero compromise on reliability”

Extensive international healthcare background involving medical technology and IT products and services, at both operational and strategic levels
Served in senior VP/General Manager positions over the past 30 years with a primary focus on sales, marketing and business development (Cardinal Health, Hill-Rom, Marquette Medical Systems and Johnson & Johnson)
Master of Science in Management with "Summa cum laude"; Certificate of Advanced Studies in Strategies in Services Programs from INSEAD; fluent in English, French and Spanish

Maurizio Moroni

Co-Founder and Chief Scientist

“To move quickly and break things’. The origins of the dianax brand name are in the merging of DIAgnostics and NAno technology. We are committed to transforming clinical diagnostics for the greatest benefit of patients and their caregivers”

Senior researcher and project manager in the fields of drugs discovery, electrochemistry & biochemical analysis
Over 25 years’ experience working in international academic institutions (Leipzig University, Germany; Osaka University, Japan)
Senior project management roles within industry (Congenia S.r.l. Bayer AG)

Corrado Ruffini

President and Chairman of the Board

Corrado is a Director Emeritus of McKinsey & Company where he spent 26 years working across several sectors and geographies, and playing many leadership roles: Office Manager in Cairo and Africa Council member, Chairman of Principal Learning, Chairman of the Knowledge and People Committee of the Banking & Securities Practice, and Global Leader of the Lean Banking special initiative. Before joining McKinsey, Corrado Ruffini worked with IBM for eight years. After leaving McKinsey, he has focused on giving back to society as Chairman of the Cieli Azzurri Onlus, a not-profit organization devoted to organizing pediatric and neonatal surgery for children in need, and playing the business angel role both directly and through the Italian Angels for Growth Association.

Gian Maurizio Argenziano

Founder/Chief Executive Officer, Arventia Group

Gian led teams of Private Equity professionals worldwide as Managing Director of ABN AMRO Capital and GE Capital, making over 80 investments in 27 years. He chaired the Tax & Legal Commission of the PE Association (AIFI) where he was board member for over 10 years. Registered with the UK FCA for controlled functions, Gian Maurizio is Professor at the Master of the LIUC University and a member of its steering committee.

Gabriele Bavagnoli

Co-Chief Executive Officer, Spactiv

Gabriele orchestrated the initial fundraising leading to the foundation of the company and was our first investor. He is Founder and Managing Director of Milano Capital, combining strategic advisory and principal investing, and Co-Founder and Co-CEO of Spactiv, a Special Purpose Acquisition Company listed in the Italian stock exchange. Previous roles include Managing Director at Idea Capital SGR and Senior Partner at McKinsey and Company.

Roberto Zanco

Co-Founder and Managing Partner, RedSeed

Roberto is the Co-Founder and Managing Partner of RedSeed Venture, a sector agnostic venture capital firm focused on investments in Italian technological companies. Roberto is a board member of different technological start-ups and small and medium-sized enterprises of RedSeed portfolio. Before RedSeed he worked in the venture capital investment team of Quadrivio SGR where he made several investments covering different industries. He started his career as a corporate finance consultant. He has a Master of Science with honors in Economics from Cà Foscari University and a Master in Business Administration from the University of Iowa (USA).

Carlo Giovanni Conti

Managing Partner, Padda Srl.

After over 15 years' experience working as a buyer in a variety of sectors, including chemistry, banking, pharmaceuticals and ceramics, Carlo embarked on a new path in the financial/investment and real estate sector with Padda Srl, an investment holding company involved in capital management and investments in biotech/life sciences start-ups.

Chantal Mathieu

MD, PhD

Professor of Medicine and Program Director of Biomedical Sciences at the Katholieke Universiteit Leuven, Belgium
Chair of Endocrinology at the University Hospital, Gasthuisberg, Leuven
Recipient of the prestigious InBev-Baillet Latour Prize for clinical research for her pioneering research on the pathogenesis of type 1 diabetes in 2013

Lorenzo Piemonti

MD

Deputy Director, Diabetes Research Institute
Head of Beta Cell Biology Unit and Human Islet Isolation Facility and Director Islet Transplantation Program (ITP), San Raffaele Diabetes Research Institute, Milan, Italy

Anders Larsson

MD, PhD

Professor, Section of Clinical Chemistry, Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden

Michelangelo Bortolin

MD

Practicing physician at Emergency Department 118 Turin, Italy
Faculty Member Disaster Medicine Fellowship at Beth Israel Deaconess Medical Center, Boston (USA) (a teaching hospital of Harvard Medical School)

Clara Camaschella

MD

Deputy Director Division of Genetics and Cell Biology, Head of the Unit ‘Regulation of iron metabolism’, Professor of Internal Medicine, University hospital San Raffaele Milan, Italy